Share

Jameela Al Salman

M.D.

Associate Professor of Medicine, Arabian Gulf University

Chief of Medical Staff for Medical Departments in Salmaniya Medical Complex

Chairperson of the hereditary blood diseases , Salmaniya Medical Complex

Senior Consultant in Infectious Diseases, Internal Medicine, and Geriatric Medicine

Dr. Al Salman is an Associate Professor in the Arabian Gulf University and is involved in a wide range of educational and research activities. She published many articles in peer reviewed journals. She led several international, regional, and local committees and quality projects. She is also in editorial Board of the several Medical Journals.


She graduated with Honor from the medical school at Arabian Gulf University. Then she joined the Salmaniya Medical complex in 1996. She holds three American Board certifications: American Board in Internal Medicine, American Board in Geriatric Medicine, American Board in Infectious Diseases. Further, she has the board in infection control and recently the American board in medical quality. Dr. Al Salman has completed her residency and fellowship programs in the United States, where she finished the internal medicine residency in Eason, Hahnemann University, Pennsylvania, USA. Then she did a fellowship in geriatric medicine at Temple University in Pennsylvania, followed by a fellowship in infectious diseases at Yale University, New Haven, Connecticut, USA.


She is a member of the Strategic and Technical Advisory Group for Antimicrobial resistance (STAG-AMR) which is the principal advisory group to the World Health Organization (WHO) on antimicrobial resistance, and a member of WHO Infection control and prevention development guidelines for COVID-19. She has received several awards locally, regional, and internationally for her scientific contribution.

- Awarded by His Majesty the King for her achievements in improving the clinical services and for the achievement in the antibiotic stewardship program and received the medal of competency from the first degree from his majesty in the national day of the kingdom December 2016.

-  Awarded the first position for Prize Khalifa Bin Salman Al Khalifa the prime minister in Bahrain in its first version for Bahraini Doctor for the achievements in medical research and innovation 2020.

- Awarded for excellence award for Arabic women in medical field for 2020 from League of Arab states.

- Awarded for the program of antibiotic stewardship for the best governmental practices for 2016 by HE the prime Minister in kingdom of Bahrain in 2016.

Jameela Al Salman

M.D.

Associate Professor of Medicine, Arabian Gulf University

Chief of Medical Staff for Medical Departments in Salmaniya Medical Complex

Chairperson of the hereditary blood diseases , Salmaniya Medical Complex

Senior Consultant in Infectious Diseases, Internal Medicine, and Geriatric Medicine

Dr. Al Salman is an Associate Professor in the Arabian Gulf University and is involved in a wide range of educational and research activities. She published many articles in peer reviewed journals. She led several international, regional, and local committees and quality projects. She is also in editorial Board of the several Medical Journals.


She graduated with Honor from the medical school at Arabian Gulf University. Then she joined the Salmaniya Medical complex in 1996. She holds three American Board certifications: American Board in Internal Medicine, American Board in Geriatric Medicine, American Board in Infectious Diseases. Further, she has the board in infection control and recently the American board in medical quality. Dr. Al Salman has completed her residency and fellowship programs in the United States, where she finished the internal medicine residency in Eason, Hahnemann University, Pennsylvania, USA. Then she did a fellowship in geriatric medicine at Temple University in Pennsylvania, followed by a fellowship in infectious diseases at Yale University, New Haven, Connecticut, USA.


She is a member of the Strategic and Technical Advisory Group for Antimicrobial resistance (STAG-AMR) which is the principal advisory group to the World Health Organization (WHO) on antimicrobial resistance, and a member of WHO Infection control and prevention development guidelines for COVID-19. She has received several awards locally, regional, and internationally for her scientific contribution.

- Awarded by His Majesty the King for her achievements in improving the clinical services and for the achievement in the antibiotic stewardship program and received the medal of competency from the first degree from his majesty in the national day of the kingdom December 2016.

-  Awarded the first position for Prize Khalifa Bin Salman Al Khalifa the prime minister in Bahrain in its first version for Bahraini Doctor for the achievements in medical research and innovation 2020.

- Awarded for excellence award for Arabic women in medical field for 2020 from League of Arab states.

- Awarded for the program of antibiotic stewardship for the best governmental practices for 2016 by HE the prime Minister in kingdom of Bahrain in 2016.

Recent Publications

A multinational Delphi consensus to end the COVID-19 public health threat

Published On 2022 Nov 04

Journal article

Despite notable scientific and medical advances, broader political, socioeconomic and behavioural factors continue to undercut the response to the COVID-19 pandemic<sup>1,2</sup>. Here we convened, as part of this Delphi study, a diverse, multidisciplinary panel of 386 academic, health, non-governmental organization, government and other experts in COVID-19 response from 112 countries and territories to recommend specific actions to end this persistent global threat to public health. The panel...


COVID-19 in the Gulf Cooperation Council Member States: An Evidence of Effective Response

Published On 2021 Sep 23

Journal article

CONCLUSIONS: All GCC states demonstrated an effective response to the pandemic, enhanced existing infrastructures, and accelerated reforms that would have otherwise taken longer. The lessons learned through the early phase of the pandemic continue to steer the states in realigning their strategies and resetting their goals of controlling the outbreak, particularly in the current context of vaccine introduction and increasing preparedness capacities for future pandemics.